prof. MUDr. Jiří Mayer, CSc.
Department head, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 3643, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 1618
2013
-
The BCR-ABL1 T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy.
Leukemia & Lymphoma, year: 2013, volume: 54, edition: 9, DOI
-
The Effect of Imatinib Treatment Duration on the Quality of the Life of Patients with Chronic Myeloid Leukemia
Journal of Blood Disorders & Transfusion, year: 2013, volume: 4, edition: 6, DOI
-
The Estimation of Current Survival Measures in Chronic Myeloid Leukemia is Now Available Online
Year: 2013, type: Conference abstract
-
The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib
Leukemia, year: 2013, volume: 27, edition: 10, DOI
-
The expression of a single microRNA -miR-34a - is a reliable marker for impairment of TP53-pathway in chronic lymphocytic leukemia
Year: 2013, type: Conference abstract
-
The expression of micrRNA-34a is a highly reliable for impairment of p53-pathway in CLL: development of clinically applicable assay
Year: 2013, type: Conference abstract
-
The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus
Leukemia Research, year: 2013, volume: 37, edition: 7, DOI
-
The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab
European Journal of Haematology, year: 2013, volume: 90, edition: 6, DOI
-
The Planar Cell Polarity Pathway Drives Pathogenesis of Chronic Lymphocytic Leukemia by the Regulation of B-Lymphocyte Migration
Cancer Research, year: 2013, volume: 73, edition: 5, DOI
-
The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts
Blood, year: 2013, volume: 121, edition: 22, DOI